BZW1 and lung carcinoma: Our findings establish BZW1 as a ferroptosis suppressor whose inhibition may synergize with immunotherapy in LUAD, highlighting the therapeutic potential of targeting the BZW1-ferroptosis axis for lung cancer treatment.